Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5860 posts found.

BioMarin reports mixed Phase III results for genetic disorder trial-drug Pegvaliase

March 22, 2016 Manufacturing and Production, Research and Development

Biotech firm BioMarin Pharmaceutical (Nasdaq: BMRN) reported mixed results for its trial drug to treat genetic disorder phenylketonuria. Trial drug, …
News

Raptor’s Procysbi gets Priority Review from Health Canada

March 22, 2016 Manufacturing and Production, Research and Development Canada, Health Canada, Procysbi, Raptor Pharmaceutical, genetic condition

Raptor Pharmaceutical (Nasdaq: RPTP) said Canadian regulators have accepted a priority review for its drug to treat a rare genetic …
News

23andMe’s apps to aid genetic research for Apple’s ResearchKit

March 22, 2016 Manufacturing and Production, Research and Development 23andME, Apple, genetics, research

Privately-held 23andMe has announced a new module for Apple’s (Nasdaq: AAPL) open source ResearchKit software framework that allows scientists to …
News
fda_building

FDA bans clinical trial co-ordinator who faked patient samples and stole funds

March 22, 2016 Manufacturing and Production, Medical Communications FDA, HIV, clinical trials, faked, forgery, mcquerry, prison

The US Food and Drug Administration has permanently banned a clinical trial co-ordinator who was found to have falsified patient …
News
albumedix

Albumedix technology extends dosing interval in Behring haemophilia B drug

March 22, 2016 Manufacturing and Production, Research and Development Albumedix, GSK, Idelvion, Novozymes, VELTIS, haemophilia B

Novozymes subsidiary Albumedix has scored another big pharma tie-up for its albumin-based half-life extension technology VELTIS, which this time is …
News
disease

FDA approves new anthrax treatment

March 22, 2016 Manufacturing and Production, Research and Development Antibacterial, FDA, US, anthim, anthrax, defense, inhalational

The US Food and Drug Administration (FDA) has approved Anthim (obiltoxaximab) to treat inhalational anthrax in combination with appropriate antibacterial …
News
takeda_research_centre

Takeda presents long-term Entyvio data in CD and UC

March 21, 2016 Manufacturing and Production, Research and Development Crohn's, Crohn's and Colitis, Entyvio, Takeda, ulcerative colitis

Japan’s Takeda has presented interim findings from the GEMINI Long-Term Safety (LTS) study of ulcerative colitis drug Entyvio (vedolizumab) at …
News

ThromboGenics signs €1m licensing deal with Galapagos for diabetic eye disease treatment

March 21, 2016 Manufacturing and Production, Research and Development, Sales and Marketing

ThromboGenics NV (Euronext Brussels: THR) on Monday said it has signed a €1 million license deal with Galapagos NV (Nasdaq: …
News
novartissunlight_copy

Novartis’s heart failure drug given final recommendation by NICE

March 21, 2016 Manufacturing and Production, Research and Development Entresto, NICE, Novartis, approval, draft, guidance, heart failure, heart failure drug

The National Institute for Health and Care Excellence (NICE) has issued its final guidance on Entresto (sacubritil/valsartan), a heart failure …
News
chugai_pharmaceutical

Chugai receive orphan drug status for autoimmune disease treatment

March 17, 2016 Manufacturing and Production, Medical Communications, Research and Development chuagi, systemic scleroderma, tocilizumab

Chugai Pharmaceutical Co. (TYO: 4519) has received a notification of orphan drug designation, from the Japanese minister of health, labour …
News
asthma_inhalers

Vectura agree £441m merger with Skyepharma

March 16, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Skyepharma, UK, biotech, merger, vectura

Vectura (LON: VEC) and Skyepharma (LON: SKP), two UK-based pharma companies, have joined together in a deal worth £441m. The …
News

Orexigen takes back rights to its weigh management drug from Takeda

March 16, 2016 Business Services, Manufacturing and Production, Sales and Marketing Contrave, Orexigen Therapeutics, akeda Pharmaceuticals

Orexigen Therapeutics (Nasdaq: OREX) has taken back the rights to its weight management drug from Japanese pharma giant Takeda Pharmaceuticals …
News
invivo

UPDATE: InVivo Therapeutics prices public offering at $7.50 per share to raise $28 million

March 15, 2016 Business Services, Manufacturing and Production, Sales and Marketing InVivo, Share price, Stake sale

InVivo Therapeutics (Nasdaq: NVIV) on Tuesday said it plans to raise about $28 million via a public offering of over …
News
valeant_logo

Valeant cuts 2016 sales, earnings outlook; shares plunge over 47%

March 15, 2016 Business Services, Manufacturing and Production, Sales and Marketing Valeant Pharma, fourth quarter, full year, results

Valeant Pharmaceuticals Inc (NYSE: VRX) cut its outlook for the first-quarter of 2016 and posted a loss for the final …
News

Cellnovo, Roche sign deal to integrate diabetes platforms

March 15, 2016 Manufacturing and Production, Sales and Marketing Cellnovo, Roche, diabetes

Cellnovo Group (Paris: CLNV) on Tuesday said it has signed a deal with Swiss drug major Roche (Euronext: ROG) to …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026